Entries tagged "biotech"
In August, Procter & Gamble wrote another chapter in its history book by selling its prescription drug business for more than $3 billion to Warner Chilcott.
Susan Desmond-Hellmann, Genentech's former chief of product development since 2004, takes over the chancellor's chair at the University of California, San Francisco.
Royalty financing techniques with respect to pharmaceutical and biotech assets are becoming broader and more complex.
How contingent value rights bridge gaps between buyers and sellers in the healthcare industry.
As the economy foundered, drug industry insiders looked forward to an M&A frenzy. But with a few exceptions, deals occurred only at the top of the food chain.
Results of a survey indicate it's a very difficult environment for any startup.
